Ebola cases top 4,000 in DRC as WHO urges Ervebo vaccine trial
As health authorities remain on alert, World Health Organization (WHO) vaccine experts on Friday recommended a full-scale human trial of the only existing approved Ebola vaccine to see if it could offer cross-protection against the deadly Bundibugyo strain spreading in DRC, a strain for which there is no vaccine.
Recommended Stories list of 3 itemslist 1 of 3‘There’s no salary’: DRC health workers tell of hardship as Ebola spreadslist 2 of 3DR Congo’s Ebola death toll passes 1,500 as it struggles to halt spreadlist 3 of 3WHO chief: Ebola outbreak in DRC spreading at ‘unprecedented rate’end of listDRC reported 4,053 Bundibugyo cases, including 1,850 deaths, since the outbreak was declared in mid-May, the latest Ministry of Health situation report showed.
Ervebo vaccine trial recommendedOn Friday, the WHO recommended the commencement of full-scale human trials for the Ervebo vaccine, the only licensed Ebola vaccine.
This is a summary of the original articles listed below. Always read the source articles for the full context. GhanaSummary does not create or modify the news — we summarise and link to original publishers.
